Head-to-head for moms
CoreAge Rx vs Coivas
CoreAge Rx and Coivas both offer GLP-1 telehealth to mothers, but they make different trade-offs on family-budget value, clinical oversight, price and access. Here they are side-by-side on the Editors' Rating — our six-factor rubric for mothers.
CoreAge Rx
Higher scoreRanked #1 · Grade A
Best for: Mothers who want to know the real monthly cost before the free trial talks them into it — one flat price on semaglutide or tirzepatide, everywhere in the country, with no lock-in.
Visit CoreAge RxCoivas
Ranked #86 · Grade C
Best for: A mother comparing flat-rate compounded sellers who wants the post-introductory number in front of her before she starts, not after.
Visit CoivasThe verdict
CoreAge Rx edges out Coivas on the Editors' Rating, 94 to 61 (A vs C). Mothers who want to know the real monthly cost before the free trial talks them into it — one flat price on semaglutide or tirzepatide, everywhere in the country, with no lock-in.
Coivas is still a genuine option — two prices are printed on the Coivas homepage and they are both true. The cards advertise semaglutide from $119 and tirzepatide from $199; the comparison block a scroll below gives $149 and $229, marked "after intro period". Most sellers publish only the first number and let you meet the second on a renewal invoice, so printing both is a point in its favor — and the second pair is what you should budget against. The medication is compounded only, held flat at every dose, and covers all 50 states. There is no Wegovy or Zepbound here, no oral option, and no mention of bloodwork anywhere on the site. Weigh the six factors below against your own priorities.
Side-by-side on the six factors
Both providers scored on the same women's-health rubric — the higher side on each factor is marked. See the methodology.
Price, access & features
| Detail | CoreAge Rx | Coivas |
|---|---|---|
| Editors' Rating | 94/100 · A | 61/100 · C |
| Overall rank | #1 | #86 |
| Semaglutide | $99/mo | $149/mo after the intro period |
| Tirzepatide | $149/mo | $229/mo after the intro period |
| Coverage | All 50 states | All 50 states |
| Brand-name access | Compounded only | Compounded only |
| Oral / sublingual | Injection only | Injection only |
CoreAge Rx
Ranked #1 · Grade A
What we like
- Flat all-in price that doesn't step up after month one — the number you sign for is the number at the full dose
- Both compounded semaglutide and tirzepatide on a single account, so a molecule switch never resets the budget
- Licensed in all 50 states — care survives a move, a deployment, or a summer at the grandparents'
The caveats
- Not the rock-bottom sticker price — a bare teaser tier elsewhere can look cheaper for exactly one month
- Compounded only; no FDA-approved brand Wegovy or Zepbound if that is what you and your clinician want
- A general metabolic program, not a dedicated women's or maternal-health clinic
Coivas
Ranked #86 · Grade C
What we like
- Publishes the ongoing price beside the introductory one instead of burying it
- One flat rate at every dose, so titrating up does not raise the bill
- All 50 states, with consultation, prescription, medication, shipping and support inside the price
The caveats
- The advertised $119 and $199 are introductory only — ongoing is $149 and $229
- Every figure carries a "from", and the site says dosage and titration can change what you pay
- Compounded only: no FDA-approved Wegovy, Ozempic, Zepbound or Mounjaro
We may earn a referral fee if you sign up through a link on this page, at no extra cost to you — and it has no bearing on which provider scores higher. Pricing, states and verification reflect each provider's public disclosures at last review; the Editors' Rating is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.
More head-to-heads
Keep comparing CoreAge Rx and Coivas against other providers we review for mothers.
Or browse the full comparison hub.